- Investing Ideas
- /
- Pharmaceuticals & Biotech High Growth Potential
Pharmaceuticals & Biotech High Growth Potential
Results
2
0 new
Some of the established companies offering high earnings growth over the next three years
2 companies
Johnson & Johnson
Market Cap: US$375.1b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$156.31
7D
0.6%
1Y
3.4%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.41
7D
1.4%
1Y
-42.8%